Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy

Amrita Goyal-O'Leary; Seth Lofgreen; Evan Mariash; Andrea L Bershow; Kevin J. Gaddis

doi:10.1111/dth.13725

Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy

Amrita Goyal-O'Leary
, Seth Lofgreen
, Evan Mariash
, Andrea L Bershow
, Kevin J. Gaddis

Dermatology

Research output: Contribution to journal › Letter › peer-review

18 Scopus citations

Original language	English (US)
Article number	e13725
Journal	Dermatologic therapy
Volume	33
Issue number	4
DOIs	https://doi.org/10.1111/dth.13725
State	Published - Jul 1 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1111/dth.13725

Find It

Find It at U of M Libraries

Cite this

@article{2db01c5c2ca848d49db89d09f7e221a1,

title = "Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy",

author = "Amrita Goyal-O'Leary and Seth Lofgreen and Evan Mariash and Bershow, \{Andrea L\} and Gaddis, \{Kevin J.\}",

year = "2020",

month = jul,

day = "1",

doi = "10.1111/dth.13725",

language = "English (US)",

volume = "33",

journal = "Dermatologic therapy",

issn = "1396-0296",

publisher = "John Wiley and Sons Inc",

number = "4",

}

TY - JOUR

T1 - Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy

AU - Goyal-O'Leary, Amrita

AU - Lofgreen, Seth

AU - Mariash, Evan

AU - Bershow, Andrea L

AU - Gaddis, Kevin J.

PY - 2020/7/1

Y1 - 2020/7/1

UR - https://www.scopus.com/pages/publications/85087401329

UR - https://www.scopus.com/pages/publications/85087401329#tab=citedBy

U2 - 10.1111/dth.13725

DO - 10.1111/dth.13725

M3 - Letter

C2 - 32558294

AN - SCOPUS:85087401329

SN - 1396-0296

VL - 33

JO - Dermatologic therapy

JF - Dermatologic therapy

IS - 4

M1 - e13725

ER -

Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy

UN SDGs

Publisher link

Find It

Other files and links

Cite this